peritoneal cancer

Showing 1 - 25 of 116

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

The PIPAC PET Pilot Study, OPC-7

Not yet recruiting
  • Peritoneal Cancer
  • +3 more
  • scan
  • (no location specified)
Nov 17, 2023

Ovarian Cancer, Ovarian Tumor, Ovarian Tumor Epithelial Trial (MIRRORS Protocol, Standard Open Cytoreductive Surgery)

Not yet recruiting
  • Ovarian Cancer
  • +5 more
  • MIRRORS Protocol
  • Standard Open Cytoreductive Surgery
  • (no location specified)
Jul 17, 2023

Cervical Cancer, Endometrial Cancer, Ovarian Cancer Trial in Seoul (Patient registry)

Recruiting
  • Cervical Cancer
  • +4 more
  • Patient registry
  • Seoul, Korea, Republic of
    Department of Obstetrics and Gynecology, University of Ulsan Col
Jun 12, 2023

Ovary Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Aurora (Mirvetuximab Soravtansine, Olaparib)

Not yet recruiting
  • Ovary Cancer
  • +2 more
  • Aurora, Colorado
    University of Colorado Hospital
May 30, 2023

Primary Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial (Huaier granule)

Not yet recruiting
  • Primary Ovarian Cancer
  • +2 more
  • Huaier granule
  • (no location specified)
Mar 29, 2023

Post Splenectomy Infections After Surgery for Peritoneal

Recruiting
  • Post-Splenectomy Infection
  • Peritoneal Cancer
  • Questionnaire, interview or observation study
  • Basingstoke, Hampshire, United Kingdom
    The Peritoneal Malignancy Institute, Hampshire Hospitals NHS Fou
Jan 30, 2023

Cancer, Solid Tumor, Ovarian Cancer Trial in Minneapolis (FT538, Enoblituzumab)

Not yet recruiting
  • Cancer
  • +4 more
  • Minneapolis, Minnesota
    Masonic Cancer Center - University of Minnesota
Jan 24, 2023

Effectiveness in Ovarian Cancer

Completed
  • Ovarian Cancer
  • +5 more
  • Baseline Biopsy
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 24, 2023

Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab Soravtansine)

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • Mirvetuximab Soravtansine
  • Phoenix, Arizona
  • +88 more
Jan 19, 2023

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine plus Bevacizumab, Bevacizumab)

Recruiting
  • Ovarian Cancer
  • +2 more
  • New Orleans, Louisiana
  • +3 more
Dec 16, 2022

Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in France

Completed
  • Epithelial Ovarian Cancer
  • +2 more
    • Agen, France
    • +136 more
    Dec 12, 2022

    Cytoreductive Surgery, Hyperthermic Intra-peritoneal Chemo, Peritoneal Cancer Trial in Seoul (Arm I (QL block and multimodal

    Recruiting
    • Cytoreductive Surgery
    • +2 more
    • Arm I (QL block and multimodal analgesia), Arm II (multimodal analgesia without regional block)
    • Seoul, Korea, Republic of
      Gangnam Severance Hospital
    Dec 2, 2022

    Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in China (Mirvetuximab Soravtansine)

    Recruiting
    • Epithelial Ovarian Cancer
    • +2 more
    • Mirvetuximab Soravtansine
    • Bengbu, Anhui, China
    • +27 more
    Nov 14, 2022

    Ovarian Cancer, Relapsed Ovarian Cancer, Fallopian Tube Cancer Trial (Carboplatin)

    Not yet recruiting
    • Ovarian Cancer
    • +6 more
    • (no location specified)
    Oct 27, 2022

    Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab Soravtansine, Paclitaxel,

    Active, not recruiting
    • Epithelial Ovarian Cancer
    • +2 more
    • Mirvetuximab Soravtansine
    • +3 more
    • Birmingham, Alabama
    • +207 more
    Oct 28, 2022

    Ovarian Cancer, Endometrial Cancer, Peritoneal Cancer Trial in Augusta (genetic testing, Survey Administration)

    Not yet recruiting
    • Ovarian Cancer
    • +2 more
    • genetic testing
    • Survey Administration
    • Augusta, Georgia
      Georgia Cancer Center at Augusta University
    Oct 27, 2022

    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Tampa (Aspirin 325mg, Placebo)

    Suspended
    • Ovarian Cancer
    • +2 more
    • Aspirin 325mg
    • Placebo
    • Tampa, Florida
      Moffitt Cancer Center
    Oct 12, 2022

    Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Houston (Telephone Counseling, Usual Care)

    Active, not recruiting
    • Ovarian Cancer
    • +2 more
    • Telephone Counseling
    • Usual Care
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Sep 22, 2022

    Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

    Recruiting
    • Ovarian Cancer
    • +68 more
    • Phoenix, Arizona
    • +8 more
    Aug 18, 2022

    Recurrent Ovarian Cancer, Recurrent Epithelial Cancer of Ovary, Recurrent Epithelial Ovarian Cancer Trial in Durham, Oklahoma

    Recruiting
    • Recurrent Ovarian Cancer
    • +6 more
    • Durham, North Carolina
    • +2 more
    Jul 26, 2022

    Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab soravtansine)

    Recruiting
    • Ovarian Cancer
    • +2 more
    • Mirvetuximab soravtansine
    • Anchorage, Alaska
    • +55 more
    Jul 25, 2022

    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Boston (Microdevice)

    Recruiting
    • Ovarian Cancer
    • +6 more
    • Microdevice
    • Boston, Massachusetts
    • +1 more
    Jul 12, 2022

    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Worldwide (tisotumab vedotin)

    Completed
    • Ovarian Cancer
    • +2 more
    • tisotumab vedotin
    • San Jose, California
    • +36 more
    Jul 8, 2022